Xcout IntelSign inSubscribe

Strides Pharma Science Limited competitors & alternatives

STARPharmaceuticalsBengaluru, India

The 12 closest competitors and alternatives to Strides Pharma Science Limited among pharmaceuticals companies — ranked by similarity to what Strides Pharma Science Limited actually does, not by market-cap band.

$951.6MMarket cap
3,065Employees
12Competitors listed

Subscribe to see Strides Pharma Science Limited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Strides Pharma Science Limited

Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.

Strides Pharma Science Limited at a glance

Strides Pharma Science Limited is a pharmaceuticals company headquartered in Bengaluru, India. It is publicly listed (STAR) with a market capitalisation of $951.6M. Xcout tracks 10 named people at Strides Pharma Science Limited, including Badree Komandur (MD & Group CEO).

Strides Pharma Science Limited leadership

  • Badree KomandurMD & Group CEO
  • Arun KumarNon-Executive Chairperson
  • Pearse HoffmannSenior Vice President of Capital Markets & Investor Relations
  • Aditya Arun KumarNon-Executive Director
  • Ameet P HarianiIndependent Director
  • Dr. Kausalya SanthanamIndependent Director

4 more named people on record for Strides Pharma Science Limited, with roles, board committees and tenure — see the full roster →

Top 12 Strides Pharma Science Limited competitors

Ranked by semantic similarity — how close each company is to Strides Pharma Science Limited by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Solara Active Pharma Sciences LimitedSOLARA · PharmaceuticalsChennai, India
69% matchPublic

Similar pharmaceuticals company

Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.

Market cap$256.9M
Employees2,156
Solara Active Pharma Sciences Limited competitors & alternatives →
Hikal LimitedHIKAL · PharmaceuticalsNavi Mumbai, India
69% matchPublic

Similar pharmaceuticals company

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Market cap$274.4M
Employees3,595
Hikal Limited competitors & alternatives →
UNITED LAB03933 · PharmaceuticalsYuen Long, Hong Kong
69% matchPublic

Similar pharmaceuticals company

The United Laboratories International Holdings Limited functions as an investment holding company with a primary focus on the pharmaceutical sector. Its multifaceted operations cover the entire lifecycle of drug development and commercialization, from pioneering research and development to manufacturing, distribution, and sales. The company structures its diverse business into three core divisions: Bulk Medicine, Intermediate Products, and Finished Goods. Its broad product portfolio features a variety of medications, such as oral antibiotics, injectable antimicrobials, cold and cough remedies, ophthalmic solutions, antiviral and anti-hepatitis B drugs, diabetes treatments, topical dermatological preparations, cardiovascular and neurological pharmaceuticals, vitamins, and empty gelatin capsules, alongside active pharmaceutical ingredients (APIs) and other intermediary compounds. Furthermore, the company manufactures and markets soft capsule shells, holds trademarks, engages in pharmaceutical trading, and provides management services. Founded in 1990 and headquartered in Yuen Long, Hong Kong, the firm maintains a significant global reach, conducting business throughout the People's Republic of China, Europe, India, the Middle East, South America, other Asian territories, and internationally.

Market cap$2.2B
Employees18,000
UNITED LAB competitors & alternatives →
Lupin LimitedLUPIN · PharmaceuticalsMumbai, India
68% matchPublic

Similar pharmaceuticals company

Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.

Market cap$11.6B
Employees19,210
Lupin Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Strides Pharma Science Limited and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Strides Pharma Science Limitedand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →